menu
    • menu
    [{"orgOrder":0,"company":"University Hospital, Montpellier","sponsor":"IntegraGen","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Lidocaine","moa":"Sodium channel alpha subunit","graph1":"Dermatology","graph2":"Undisclosed","graph3":"University Hospital, Montpellier","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Gel","sponsorNew":"University Hospital, Montpellier \/ IntegraGen","highestDevelopmentStatusID":"1","companyTruncated":"University Hospital, Montpellier \/ IntegraGen"},{"orgOrder":0,"company":"Egymedicalpedia","sponsor":"Aswan University","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"Tranexamic Acid","moa":"Plasminogen","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Egymedicalpedia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Egymedicalpedia \/ Aswan University","highestDevelopmentStatusID":"1","companyTruncated":"Egymedicalpedia \/ Aswan University"},{"orgOrder":0,"company":"Revance Therapeutics","sponsor":"Viatris","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Other Large Molecule","year":"2020","type":"Licensing Agreement","leadProduct":"Onabotulinumtoxin A","moa":"ACh release","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Revance Therapeutics","amount2":0.10000000000000001,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0.10000000000000001,"dosageForm":"Injection","sponsorNew":"Revance Therapeutics \/ Viatris","highestDevelopmentStatusID":"1","companyTruncated":"Revance Therapeutics \/ Viatris"},{"orgOrder":0,"company":"Avra","sponsor":"Springs Rejuvenation","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2021","type":"Merger","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Avra","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Avra \/ Springs Rejuvenation","highestDevelopmentStatusID":"1","companyTruncated":"Avra \/ Springs Rejuvenation"},{"orgOrder":0,"company":"Nestle Health Sciences SA","sponsor":"Medidata Solutions | SAS Institute | Veeva Systems | Cognizant Technology Solutions","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Intact Cow\\'S Milk Protein Formula","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nestle Health Sciences SA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Powder","sponsorNew":"Nestle Health Sciences SA \/ Medidata Solutions | SAS Institute | Veeva Systems | Cognizant Technology Solutions","highestDevelopmentStatusID":"1","companyTruncated":"Nestle Health Sciences SA \/ Medidata Solutions | SAS Institute | Veeva Systems | Cognizant Technology Solutions"},{"orgOrder":0,"company":"Abyss Ingredients","sponsor":"Eurofins CDMO","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"ACT01","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Abyss Ingredients","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Abyss Ingredients \/ Eurofins CDMO","highestDevelopmentStatusID":"1","companyTruncated":"Abyss Ingredients \/ Eurofins CDMO"},{"orgOrder":0,"company":"Nutraceutical Wellness Inc.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nutraceutical Wellness Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutraceutical Wellness Inc. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Nutraceutical Wellness Inc. \/ Inapplicable"},{"orgOrder":0,"company":"Newsoara Biopharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"HPP737","moa":"PDE4","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Newsoara Biopharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Newsoara Biopharma \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Newsoara Biopharma \/ Inapplicable"},{"orgOrder":0,"company":"Laboratoires Pharmaceutiques Trenker","sponsor":"Complife Italia S.r.l | Universit\u00e0 degli Studi di Pavia","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Alline Promen","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Laboratoires Pharmaceutiques Trenker","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Laboratoires Pharmaceutiques Trenker \/ Complife Italia S.r.l | Universit\u00e0 degli Studi di Pavia","highestDevelopmentStatusID":"1","companyTruncated":"Laboratoires Pharmaceutiques Trenker \/ Complife Italia S.r.l | Universit\u00e0 degli Studi di Pavia"},{"orgOrder":0,"company":"Glac Biotech Co., Ltd","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Bifidobacterium Longum CCFM1029","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Glac Biotech Co., Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Glac Biotech Co., Ltd \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Glac Biotech Co., Ltd \/ Inapplicable"},{"orgOrder":0,"company":"SunWay Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"TAIWAN","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Lactic Acid Bacteria NTU 101","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"SunWay Biotech","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"SunWay Biotech \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"SunWay Biotech \/ Inapplicable"},{"orgOrder":0,"company":"Max Planck","sponsor":"Scinai Immunotherapeutics","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Licensing Agreement","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Max Planck","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Max Planck \/ Scinai Immunotherapeutics","highestDevelopmentStatusID":"1","companyTruncated":"Max Planck \/ Scinai Immunotherapeutics"},{"orgOrder":0,"company":"Pharmanex","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Beauty Drink","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Pharmanex","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Powder","sponsorNew":"Pharmanex \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Pharmanex \/ Inapplicable"},{"orgOrder":0,"company":"Centre for Human Drug Research","sponsor":"Johnson & Johnson Innovative Medicine","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"NETHERLANDS","productType":"Antibody","year":"2020","type":"Inapplicable","leadProduct":"Guselkumab","moa":"Interleukin-23","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Centre for Human Drug Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Centre for Human Drug Research \/ Johnson & Johnson Innovative Medicine","highestDevelopmentStatusID":"1","companyTruncated":"Centre for Human Drug Research \/ Johnson & Johnson Innovative Medicine"},{"orgOrder":0,"company":"JT Pharmaceuticals","sponsor":"Titan Pharmaceuticals Inc","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Peptide","year":"2020","type":"Acquisition","leadProduct":"JT-09","moa":"Kappa opioid receptor","graph1":"Dermatology","graph2":"Undisclosed","graph3":"JT Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Injection","sponsorNew":"JT Pharmaceuticals \/ Titan Pharmaceuticals Inc","highestDevelopmentStatusID":"1","companyTruncated":"JT Pharmaceuticals \/ Titan Pharmaceuticals Inc"},{"orgOrder":0,"company":"Nakhia Impex","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Hyaluronan Fragment HA35","moa":"CD44 \/ ECM components","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nakhia Impex","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Nakhia Impex \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Nakhia Impex \/ Inapplicable"},{"orgOrder":0,"company":"Merakris Therapeutics","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"MTX-001","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Merakris Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Merakris Therapeutics \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Merakris Therapeutics \/ Inapplicable"},{"orgOrder":0,"company":"Cosmetique Active International","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Cosmetique Active International","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Serum","sponsorNew":"Cosmetique Active International \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Cosmetique Active International \/ Inapplicable"},{"orgOrder":0,"company":"Cosmetique Active International","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Cosmetique Active International","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Serum","sponsorNew":"Cosmetique Active International \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Cosmetique Active International \/ Inapplicable"},{"orgOrder":0,"company":"Pierre Fabre","sponsor":"Centre National de la Recherche Scientifique, France | INSERM","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"FRANCE","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Pierre Fabre","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pierre Fabre \/ Centre National de la Recherche Scientifique, France | INSERM","highestDevelopmentStatusID":"1","companyTruncated":"Pierre Fabre \/ Centre National de la Recherche Scientifique, France | INSERM"},{"orgOrder":0,"company":"Dairy Goat Co-operative (N.Z.) Limited","sponsor":"Klinikum der Universit\u00e4t M\u00fcnchen","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2020","type":"Inapplicable","leadProduct":"Infant Formula","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Dairy Goat Co-operative (N.Z.) Limited","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Dairy Goat Co-operative (N.Z.) Limited \/ Klinikum der Universit\u00e4t M\u00fcnchen","highestDevelopmentStatusID":"1","companyTruncated":"Dairy Goat Co-operative (N.Z.) Limited \/ Klinikum der Universit\u00e4t M\u00fcnchen"},{"orgOrder":0,"company":"Pharmanex","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Beauty Image","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Pharmanex","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pharmanex \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Pharmanex \/ Inapplicable"},{"orgOrder":0,"company":"Cynosure","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Cynosure","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Cynosure \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Cynosure \/ Inapplicable"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"TCI66207","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"Saie Beauty","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Saie Beauty\\'S Hydrabeam Sheer Brightening Under Eye Concealer","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Saie Beauty","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Saie Beauty \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Saie Beauty \/ Inapplicable"},{"orgOrder":0,"company":"United Pharmaceuticals","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"JORDAN","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Fiber","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"United Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"United Pharmaceuticals \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"United Pharmaceuticals \/ Inapplicable"},{"orgOrder":0,"company":"Let's Disco","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Daily Skin Supplement","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Let's Disco","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Let's Disco \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Let's Disco \/ Citruslabs"},{"orgOrder":0,"company":"Nutraceutical Wellness Inc.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Nutrafol Vegan Women\\'S Hair Supplement","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nutraceutical Wellness Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutraceutical Wellness Inc. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Nutraceutical Wellness Inc. \/ Inapplicable"},{"orgOrder":0,"company":"Nutraceutical Wellness Inc.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Nutrafol Men Hair Growth","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nutraceutical Wellness Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutraceutical Wellness Inc. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Nutraceutical Wellness Inc. \/ Inapplicable"},{"orgOrder":0,"company":"Academisch Medisch Centrum - Universiteit van Amsterdam","sponsor":"ZonMw","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Academisch Medisch Centrum - Universiteit van Amsterdam","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Ointment","sponsorNew":"Academisch Medisch Centrum - Universiteit van Amsterdam \/ ZonMw","highestDevelopmentStatusID":"1","companyTruncated":"Academisch Medisch Centrum - Universiteit van Amsterdam \/ ZonMw"},{"orgOrder":0,"company":"NovoBliss Research","sponsor":"Zywie Ventures Private Limited","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Seszen-Bio","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"NovoBliss Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NovoBliss Research \/ Zywie Ventures Private Limited","highestDevelopmentStatusID":"1","companyTruncated":"NovoBliss Research \/ Zywie Ventures Private Limited"},{"orgOrder":0,"company":"Bioiberica","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"SPAIN","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"HA Matrix","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Bioiberica","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bioiberica \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Bioiberica \/ Inapplicable"},{"orgOrder":0,"company":"Merz Pharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Pantovigar Vegan","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Merz Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Merz Pharma \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Merz Pharma \/ Inapplicable"},{"orgOrder":0,"company":"Farmoquimica","sponsor":"Kosmoscience Ci\u00eancia e Tecnologia Cosm\u00e9tica Ltda","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Power Supplement","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Farmoquimica","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Farmoquimica \/ Kosmoscience Ci\u00eancia e Tecnologia Cosm\u00e9tica Ltda","highestDevelopmentStatusID":"1","companyTruncated":"Farmoquimica \/ Kosmoscience Ci\u00eancia e Tecnologia Cosm\u00e9tica Ltda"},{"orgOrder":0,"company":"Integrative Skin Science and Research","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Integrative Skin Science and Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Integrative Skin Science and Research \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Integrative Skin Science and Research \/ Inapplicable"},{"orgOrder":0,"company":"Nutraceutical Wellness Inc.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nutraceutical Wellness Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutraceutical Wellness Inc. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Nutraceutical Wellness Inc. \/ Inapplicable"},{"orgOrder":0,"company":"M\u00f8reforsking AS","sponsor":"Helse M\u00f8re og Romsdal HF | EPAX NORWAY AS | University of Manchester","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"LC-MUFA","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"M\u00f8reforsking AS","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"M\u00f8reforsking AS \/ Helse M\u00f8re og Romsdal HF | EPAX NORWAY AS | University of Manchester","highestDevelopmentStatusID":"1","companyTruncated":"M\u00f8reforsking AS \/ Helse M\u00f8re og Romsdal HF | EPAX NORWAY AS | University of Manchester"},{"orgOrder":0,"company":"Nutracore","sponsor":"Novarex","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Keranat","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nutracore","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutracore \/ Novarex","highestDevelopmentStatusID":"1","companyTruncated":"Nutracore \/ Novarex"},{"orgOrder":0,"company":"Nutraceutical Wellness Inc.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Nutrafol Women\\'S Hair Growth Supplemnt","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nutraceutical Wellness Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutraceutical Wellness Inc. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Nutraceutical Wellness Inc. \/ Inapplicable"},{"orgOrder":0,"company":"Austin Institute for Clinical Research","sponsor":"SkinCeuticals","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Austin Institute for Clinical Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Austin Institute for Clinical Research \/ SkinCeuticals","highestDevelopmentStatusID":"1","companyTruncated":"Austin Institute for Clinical Research \/ SkinCeuticals"},{"orgOrder":0,"company":"Nutraceutical Wellness Inc.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Nutrafol Women\\'S Hair Growth Supplement","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nutraceutical Wellness Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutraceutical Wellness Inc. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Nutraceutical Wellness Inc. \/ Inapplicable"},{"orgOrder":0,"company":"Seeding, Inc DBA Tiny Health","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Seeding, Inc DBA Tiny Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Seeding, Inc DBA Tiny Health \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Seeding, Inc DBA Tiny Health \/ Inapplicable"},{"orgOrder":0,"company":"Finzelberg GmbH & Co. KG","sponsor":"Eurofins CDMO | Eurofins Dermscan","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"GERMANY","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Food Supplement","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Finzelberg GmbH & Co. KG","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Powder","sponsorNew":"Finzelberg GmbH & Co. KG \/ Eurofins CDMO | Eurofins Dermscan","highestDevelopmentStatusID":"1","companyTruncated":"Finzelberg GmbH & Co. KG \/ Eurofins CDMO | Eurofins Dermscan"},{"orgOrder":0,"company":"Shanghai Meifute Biotechnology Co., Ltd","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Shanghai Meifute Biotechnology Co., Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Shanghai Meifute Biotechnology Co., Ltd \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Shanghai Meifute Biotechnology Co., Ltd \/ Inapplicable"},{"orgOrder":0,"company":"Truology","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Truology A2","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Truology","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Truology \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Truology \/ Citruslabs"},{"orgOrder":0,"company":"Fondazione Policlinico Universitario Agostino Gemelli","sponsor":"Leo Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Fondazione Policlinico Universitario Agostino Gemelli","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fondazione Policlinico Universitario Agostino Gemelli \/ Leo Pharma","highestDevelopmentStatusID":"1","companyTruncated":"Fondazione Policlinico Universitario Agostino Gemelli \/ Leo Pharma"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Resveratrol","moa":"NLRP3\/SIRT1","graph1":"Dermatology","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"GSK","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"UNITED KINGDOM","productType":"Peptide","year":"2020","type":"Inapplicable","leadProduct":"Substance P","moa":"Substance-P receptor (TACR1)","graph1":"Dermatology","graph2":"Undisclosed","graph3":"GSK","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"GSK \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"GSK \/ Inapplicable"},{"orgOrder":0,"company":"Embody Beauty, Inc.","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2021","type":"Inapplicable","leadProduct":"Vitamin A","moa":"NR1B","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Embody Beauty, Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Embody Beauty, Inc. \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Embody Beauty, Inc. \/ Citruslabs"},{"orgOrder":0,"company":"Croma-Pharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"AUSTRIA","productType":"Other Small Molecule","year":"2021","type":"Inapplicable","leadProduct":"Lidocaine","moa":"Sodium channel alpha subunit","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Croma-Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Croma-Pharma \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Croma-Pharma \/ Inapplicable"},{"orgOrder":0,"company":"Chemist Confessions, Inc.","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2021","type":"Inapplicable","leadProduct":"Vitamin A","moa":"NR1B","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Chemist Confessions, Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Chemist Confessions, Inc. \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Chemist Confessions, Inc. \/ Citruslabs"},{"orgOrder":0,"company":"Emoled","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2021","type":"Inapplicable","leadProduct":"Hyaluronic Acid","moa":"Collagen synthesis","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Emoled","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Foam","sponsorNew":"Emoled \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Emoled \/ Inapplicable"},{"orgOrder":0,"company":"University of New Mexico","sponsor":"AbbVie Inc","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2023","type":"Inapplicable","leadProduct":"Zinc Citrate","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"University of New Mexico","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of New Mexico \/ AbbVie Inc","highestDevelopmentStatusID":"1","companyTruncated":"University of New Mexico \/ AbbVie Inc"},{"orgOrder":0,"company":"Austin Institute for Clinical Research","sponsor":"SkinCeuticals","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2023","type":"Inapplicable","leadProduct":"Ascorbic Acid","moa":"Collagen (CO)","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Austin Institute for Clinical Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Austin Institute for Clinical Research \/ SkinCeuticals","highestDevelopmentStatusID":"1","companyTruncated":"Austin Institute for Clinical Research \/ SkinCeuticals"},{"orgOrder":0,"company":"Egymedicalpedia","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Calcipotriol","moa":"Vitamin D receptor","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Egymedicalpedia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Egymedicalpedia \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Egymedicalpedia \/ Inapplicable"},{"orgOrder":0,"company":"Galderma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"SWITZERLAND","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"L-Lactic Acid","moa":"Vaginal pH","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Galderma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Galderma \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Galderma \/ Inapplicable"},{"orgOrder":0,"company":"Nutrition 21, Inc.","sponsor":"ALS Beauty and Personal Care","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Biotin","moa":"Krebs cycle activatior","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nutrition 21, Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrition 21, Inc. \/ ALS Beauty and Personal Care","highestDevelopmentStatusID":"1","companyTruncated":"Nutrition 21, Inc. \/ ALS Beauty and Personal Care"},{"orgOrder":0,"company":"Lili Legiawati","sponsor":"Ministry of Education, Culture, Research, and Technology, Indonesia | PT KIMIA FARMA PERSERO TBK","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Minoxidil","moa":"Sulfonylurea receptor 2, Kir6.2","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Lili Legiawati","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lili Legiawati \/ Ministry of Education, Culture, Research, and Technology, Indonesia | PT KIMIA FARMA PERSERO TBK","highestDevelopmentStatusID":"1","companyTruncated":"Lili Legiawati \/ Ministry of Education, Culture, Research, and Technology, Indonesia | PT KIMIA FARMA PERSERO TBK"},{"orgOrder":0,"company":"ACOM Labs","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Steroid","year":"2023","type":"Inapplicable","leadProduct":"Triamcinolone","moa":"Glucocorticoid receptor","graph1":"Dermatology","graph2":"Undisclosed","graph3":"ACOM Labs","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Injection","sponsorNew":"ACOM Labs \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"ACOM Labs \/ Inapplicable"},{"orgOrder":0,"company":"Irma Bernadette","sponsor":"Menarini","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Kojic Acid","moa":"Tyrosinase (TYR)","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Irma Bernadette","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Solution","sponsorNew":"Irma Bernadette \/ Menarini","highestDevelopmentStatusID":"1","companyTruncated":"Irma Bernadette \/ Menarini"},{"orgOrder":0,"company":"Fundacion Rioja Salud","sponsor":"Pharmamel | Universidad de Granada | Instituto de Salud Carlos III","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"Melatonin","moa":"Melatonin receptor","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Fundacion Rioja Salud","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Fundacion Rioja Salud \/ Pharmamel | Universidad de Granada | Instituto de Salud Carlos III","highestDevelopmentStatusID":"1","companyTruncated":"Fundacion Rioja Salud \/ Pharmamel | Universidad de Granada | Instituto de Salud Carlos III"},{"orgOrder":0,"company":"Activ'inside","sponsor":"Complife Italia Srl","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Plant Extract\/Herbal","year":"2024","type":"Inapplicable","leadProduct":"Green Tea Extract","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Activ'inside","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Activ'inside \/ Complife Italia Srl","highestDevelopmentStatusID":"1","companyTruncated":"Activ'inside \/ Complife Italia Srl"},{"orgOrder":0,"company":"Nutra Harmony LLC","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"Biotin","moa":"Krebs cycle activatior","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nutra Harmony LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutra Harmony LLC \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Nutra Harmony LLC \/ Inapplicable"},{"orgOrder":0,"company":"Henry Ford Health System","sponsor":"Next Science","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2025","type":"Inapplicable","leadProduct":"Hydrogen Peroxide","moa":"PTPN1 messenger RNA (PTPN1 mRNA)","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Henry Ford Health System","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Henry Ford Health System \/ Next Science","highestDevelopmentStatusID":"1","companyTruncated":"Henry Ford Health System \/ Next Science"},{"orgOrder":0,"company":"Applied Biology","sponsor":"Corpometria Institute","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Other Small Molecule","year":"2020","type":"Collaboration","leadProduct":"Proxalutamide","moa":"Androgen Receptor","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Applied Biology","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Applied Biology \/ Corpometria Institute","highestDevelopmentStatusID":"1","companyTruncated":"Applied Biology \/ Corpometria Institute"},{"orgOrder":0,"company":"Sirona Biochem Corp","sponsor":"Allergan Aesthetics","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"CANADA","productType":"Other Small Molecule","year":"2022","type":"Licensing Agreement","leadProduct":"Difluorocyclohexyloxyphenol","moa":"hTyr","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Sirona Biochem Corp","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Sirona Biochem Corp \/ Allergan Aesthetics","highestDevelopmentStatusID":"1","companyTruncated":"Sirona Biochem Corp \/ Allergan Aesthetics"},{"orgOrder":0,"company":"Sirona Biochem Corp","sponsor":"RODAN & FIELDS LLC","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"CANADA","productType":"Other Small Molecule","year":"2022","type":"Termination","leadProduct":"Difluorocyclohexyloxyphenol","moa":"hTyr","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Sirona Biochem Corp","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Sirona Biochem Corp \/ RODAN & FIELDS LLC","highestDevelopmentStatusID":"1","companyTruncated":"Sirona Biochem Corp \/ RODAN & FIELDS LLC"},{"orgOrder":0,"company":"Sirona Biochem Corp","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"CANADA","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Difluorocyclohexyloxyphenol","moa":"hTyr","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Sirona Biochem Corp","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Sirona Biochem Corp \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Sirona Biochem Corp \/ Inapplicable"},{"orgOrder":0,"company":"Sirona Biochem Corp","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"CANADA","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Difluorocyclohexyloxyphenol","moa":"hTyr","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Sirona Biochem Corp","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Sirona Biochem Corp \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Sirona Biochem Corp \/ Inapplicable"},{"orgOrder":0,"company":"Sirona Biochem Corp","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"CANADA","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Difluorocyclohexyloxyphenol","moa":"hTyr","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Sirona Biochem Corp","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Sirona Biochem Corp \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Sirona Biochem Corp \/ Inapplicable"},{"orgOrder":0,"company":"Sirona Biochem Corp","sponsor":"Undisclosed","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"CANADA","productType":"Other Small Molecule","year":"2020","type":"Agreement","leadProduct":"Difluorocyclohexyloxyphenol","moa":"hTyr","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Sirona Biochem Corp","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Sirona Biochem Corp \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Sirona Biochem Corp \/ Undisclosed"},{"orgOrder":0,"company":"Sirona Biochem Corp","sponsor":"Promura GmbH","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"CANADA","productType":"Other Small Molecule","year":"2025","type":"Private Placement","leadProduct":"Difluorocyclohexyloxyphenol","moa":"hTyr","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Sirona Biochem Corp","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Sirona Biochem Corp \/ Promura GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Sirona Biochem Corp \/ Promura GmbH"},{"orgOrder":0,"company":"PT. Daewoong Infion","sponsor":"Equilab International","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Peptide","year":"2022","type":"Inapplicable","leadProduct":"Recombinant Human Epidermal Growth Factor","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"PT. Daewoong Infion","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Spray","sponsorNew":"PT. Daewoong Infion \/ Equilab International","highestDevelopmentStatusID":"1","companyTruncated":"PT. Daewoong Infion \/ Equilab International"},{"orgOrder":0,"company":"Florida Academic Centers Research and Education, LLC","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Peptide","year":"2024","type":"Inapplicable","leadProduct":"Tirzepatide","moa":"Glucagon-like peptide 1 receptor | Gastric inhibitory polypeptide receptor","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Florida Academic Centers Research and Education, LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Florida Academic Centers Research and Education, LLC \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Florida Academic Centers Research and Education, LLC \/ Inapplicable"},{"orgOrder":0,"company":"Croma-Pharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"AUSTRIA","productType":"Peptide-drug Conjugate","year":"2021","type":"Inapplicable","leadProduct":"Saypha Volume Lidocaine","moa":"Homeostasis","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Croma-Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Croma-Pharma \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Croma-Pharma \/ Inapplicable"},{"orgOrder":0,"company":"Integrative Skin Science and Research","sponsor":"Verdure Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Red Maple Leaf Extract","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Integrative Skin Science and Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Integrative Skin Science and Research \/ Verdure Sciences","highestDevelopmentStatusID":"1","companyTruncated":"Integrative Skin Science and Research \/ Verdure Sciences"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Banana Flower Extract","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"Primus Pharmaceutical","sponsor":"Northeastern University","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Diosmiplex","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Primus Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Primus Pharmaceutical \/ Northeastern University","highestDevelopmentStatusID":"1","companyTruncated":"Primus Pharmaceutical \/ Northeastern University"},{"orgOrder":0,"company":"Archer Daniels Midland","sponsor":"Eurofins Dermscan","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2023","type":"Inapplicable","leadProduct":"Soy Isoflavone","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Archer Daniels Midland","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Archer Daniels Midland \/ Eurofins Dermscan","highestDevelopmentStatusID":"1","companyTruncated":"Archer Daniels Midland \/ Eurofins Dermscan"},{"orgOrder":0,"company":"Integrative Skin Science and Research","sponsor":"Vidya Herbs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Plant Extract\/Herbal","year":"2023","type":"Inapplicable","leadProduct":"Herbal Supplement","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Integrative Skin Science and Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Integrative Skin Science and Research \/ Vidya Herbs","highestDevelopmentStatusID":"1","companyTruncated":"Integrative Skin Science and Research \/ Vidya Herbs"},{"orgOrder":0,"company":"Integrative Skin Science and Research","sponsor":"Microbiome labs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Probiotic","year":"2020","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Integrative Skin Science and Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Integrative Skin Science and Research \/ Microbiome labs","highestDevelopmentStatusID":"1","companyTruncated":"Integrative Skin Science and Research \/ Microbiome labs"},{"orgOrder":0,"company":"Chang Gung Memorial Hospital","sponsor":"Glac Biotech Co., Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Probiotic Lactobacillus Salivarius AP-32","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Chang Gung Memorial Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Chang Gung Memorial Hospital \/ Glac Biotech Co., Ltd","highestDevelopmentStatusID":"1","companyTruncated":"Chang Gung Memorial Hospital \/ Glac Biotech Co., Ltd"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"TCI999","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"Bionou Research, S.L.","sponsor":"Biopolis S.L.","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Bionou Research, S.L.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bionou Research, S.L. \/ Biopolis S.L.","highestDevelopmentStatusID":"1","companyTruncated":"Bionou Research, S.L. \/ Biopolis S.L."},{"orgOrder":0,"company":"Bioithas SL","sponsor":"Bionou Research, S.L.","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Bioithas SL","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bioithas SL \/ Bionou Research, S.L.","highestDevelopmentStatusID":"1","companyTruncated":"Bioithas SL \/ Bionou Research, S.L."},{"orgOrder":0,"company":"Integrative Skin Science and Research","sponsor":"Codex Labs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Integrative Skin Science and Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Integrative Skin Science and Research \/ Codex Labs","highestDevelopmentStatusID":"1","companyTruncated":"Integrative Skin Science and Research \/ Codex Labs"},{"orgOrder":0,"company":"Texas Tech University","sponsor":"Legion Athletics, Inc","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Creatine Monohydrate","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Texas Tech University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Texas Tech University \/ Legion Athletics, Inc","highestDevelopmentStatusID":"1","companyTruncated":"Texas Tech University \/ Legion Athletics, Inc"},{"orgOrder":0,"company":"VIST","sponsor":"Tosla d.o.o. | Slovenian Research Agency","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Protein","year":"2021","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Dermatology","graph2":"Undisclosed","graph3":"VIST","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"VIST \/ Tosla d.o.o. | Slovenian Research Agency","highestDevelopmentStatusID":"1","companyTruncated":"VIST \/ Tosla d.o.o. | Slovenian Research Agency"},{"orgOrder":0,"company":"Northwell Health","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Botulinum toxin type A","moa":"Synaptosomal nerve-associated protein 25 (SNAP-25)","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Northwell Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Northwell Health \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Northwell Health \/ Inapplicable"},{"orgOrder":0,"company":"Revision Skincare","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Botulinum toxin type A","moa":"Synaptosomal nerve-associated protein 25 (SNAP-25)","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Revision Skincare","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Revision Skincare \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Revision Skincare \/ Inapplicable"},{"orgOrder":0,"company":"NovoBliss Research","sponsor":"Collagen Lifesciences Private Limited","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Protein","year":"2022","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Dermatology","graph2":"Undisclosed","graph3":"NovoBliss Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NovoBliss Research \/ Collagen Lifesciences Private Limited","highestDevelopmentStatusID":"1","companyTruncated":"NovoBliss Research \/ Collagen Lifesciences Private Limited"},{"orgOrder":0,"company":"Scale Media Inc","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Protein","year":"2024","type":"Inapplicable","leadProduct":"Live Conscious Beyond Collagen","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Scale Media Inc","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Scale Media Inc \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Scale Media Inc \/ Citruslabs"},{"orgOrder":0,"company":"Simply Plus Co., Ltd.","sponsor":"Chia Nan University of Pharmacy and Science","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Protein","year":"2025","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Simply Plus Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Simply Plus Co., Ltd. \/ Chia Nan University of Pharmacy and Science","highestDevelopmentStatusID":"1","companyTruncated":"Simply Plus Co., Ltd. \/ Chia Nan University of Pharmacy and Science"},{"orgOrder":0,"company":"CollPlant","sponsor":"Allergan Aesthetics","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"ISRAEL","productType":"Protein","year":"2021","type":"Collaboration","leadProduct":"rhCollagen","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"CollPlant","amount2":0.10000000000000001,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0.10000000000000001,"dosageForm":"Injection","sponsorNew":"CollPlant \/ Allergan Aesthetics","highestDevelopmentStatusID":"1","companyTruncated":"CollPlant \/ Allergan Aesthetics"},{"orgOrder":0,"company":"Ingenza","sponsor":"Amplifica","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"UNITED KINGDOM","productType":"Undisclosed","year":"2023","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Ingenza","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ingenza \/ Amplifica","highestDevelopmentStatusID":"1","companyTruncated":"Ingenza \/ Amplifica"},{"orgOrder":0,"company":"WuXi Biologics","sponsor":"Almirall","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"CHINA","productType":"Undisclosed","year":"2020","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"WuXi Biologics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"WuXi Biologics \/ Almirall","highestDevelopmentStatusID":"1","companyTruncated":"WuXi Biologics \/ Almirall"},{"orgOrder":0,"company":"Crescita Therapeutics","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"CANADA","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Crescita Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Crescita Therapeutics \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Crescita Therapeutics \/ Inapplicable"},{"orgOrder":0,"company":"Arbor Life Labs","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"ALRV5XR","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Arbor Life Labs","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Arbor Life Labs \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Arbor Life Labs \/ Inapplicable"},{"orgOrder":0,"company":"Arbor Life Labs","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"ALRV5XR","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Arbor Life Labs","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Arbor Life Labs \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Arbor Life Labs \/ Inapplicable"},{"orgOrder":0,"company":"Johnson & Johnson","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Moisturizer","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Johnson & Johnson","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Johnson & Johnson \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Johnson & Johnson \/ Inapplicable"},{"orgOrder":0,"company":"Revision Skincare","sponsor":"Ablon Skin Institute Research Center","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Sunscreen","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Revision Skincare","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Serum","sponsorNew":"Revision Skincare \/ Ablon Skin Institute Research Center","highestDevelopmentStatusID":"1","companyTruncated":"Revision Skincare \/ Ablon Skin Institute Research Center"},{"orgOrder":0,"company":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","sponsor":"ZonMw","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Corticosteroid","moa":"Glucocorticoid receptor","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Pill","sponsorNew":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation \/ ZonMw","highestDevelopmentStatusID":"1","companyTruncated":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation \/ ZonMw"},{"orgOrder":0,"company":"Unilever","sponsor":"Shanghai Skin Disease and Venereal Disease Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Q69","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Unilever","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Serum","sponsorNew":"Unilever \/ Shanghai Skin Disease and Venereal Disease Hospital","highestDevelopmentStatusID":"1","companyTruncated":"Unilever \/ Shanghai Skin Disease and Venereal Disease Hospital"},{"orgOrder":0,"company":"AMOREPACIFIC CORPORATION","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"SOUTH KOREA","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"AP Collagen","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"AMOREPACIFIC CORPORATION","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"AMOREPACIFIC CORPORATION \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"AMOREPACIFIC CORPORATION \/ Inapplicable"},{"orgOrder":0,"company":"Chia Nan University of Pharmacy and Science","sponsor":"Glac Biotech Co., Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Tac","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Chia Nan University of Pharmacy and Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Chia Nan University of Pharmacy and Science \/ Glac Biotech Co., Ltd","highestDevelopmentStatusID":"1","companyTruncated":"Chia Nan University of Pharmacy and Science \/ Glac Biotech Co., Ltd"},{"orgOrder":0,"company":"Gateway Health Alliance","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Dyglomera","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Gateway Health Alliance","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Gateway Health Alliance \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Gateway Health Alliance \/ Inapplicable"},{"orgOrder":0,"company":"Guangdong HuaPeptides Biotechnology Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Collagen Tripeptide","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Guangdong HuaPeptides Biotechnology Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Guangdong HuaPeptides Biotechnology Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Guangdong HuaPeptides Biotechnology Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"Shenzhen Precision Health Food Technology Co. Ltd.,","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Collagen Tripeptide","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Shenzhen Precision Health Food Technology Co. Ltd.,","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Shenzhen Precision Health Food Technology Co. Ltd., \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Shenzhen Precision Health Food Technology Co. Ltd., \/ Inapplicable"},{"orgOrder":0,"company":"VIST","sponsor":"Tosla d.o.o. | Slovenian Research Agency","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"CP5HA","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"VIST","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"VIST \/ Tosla d.o.o. | Slovenian Research Agency","highestDevelopmentStatusID":"1","companyTruncated":"VIST \/ Tosla d.o.o. | Slovenian Research Agency"},{"orgOrder":0,"company":"Fundaci\u00f3 Eurecat","sponsor":"Euromed, S.A.","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Pomanox","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Fundaci\u00f3 Eurecat","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fundaci\u00f3 Eurecat \/ Euromed, S.A.","highestDevelopmentStatusID":"1","companyTruncated":"Fundaci\u00f3 Eurecat \/ Euromed, S.A."},{"orgOrder":0,"company":"Amway (China) R&D Center","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Amway Herbal Drink","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Amway (China) R&D Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Amway (China) R&D Center \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Amway (China) R&D Center \/ Inapplicable"},{"orgOrder":0,"company":"Wecare Probiotics Co., Ltd.","sponsor":"Methodex","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Probiotic LRa05","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Wecare Probiotics Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Wecare Probiotics Co., Ltd. \/ Methodex","highestDevelopmentStatusID":"1","companyTruncated":"Wecare Probiotics Co., Ltd. \/ Methodex"},{"orgOrder":0,"company":"Clarteis","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Exciplex","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Clarteis","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Clarteis \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Clarteis \/ Inapplicable"},{"orgOrder":0,"company":"Natals, Inc. dba Ritual","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Hyacera","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Natals, Inc. dba Ritual","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Natals, Inc. dba Ritual \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Natals, Inc. dba Ritual \/ Inapplicable"},{"orgOrder":0,"company":"Applied Biology","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"DA-OTC-002","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Applied Biology","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Applied Biology \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Applied Biology \/ Inapplicable"},{"orgOrder":0,"company":"BrandiZone","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Hair Nutra Growth Supplement","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"BrandiZone","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"BrandiZone \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"BrandiZone \/ Citruslabs"},{"orgOrder":0,"company":"Botanee Group","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"MLYAAT-1002","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Botanee Group","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Botanee Group \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Botanee Group \/ Inapplicable"},{"orgOrder":0,"company":"SCF Pharma","sponsor":"Institut de recherche clinique du littoral","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Omega-3 Monoglyceride","moa":"Lipid","graph1":"Dermatology","graph2":"Undisclosed","graph3":"SCF Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"SCF Pharma \/ Institut de recherche clinique du littoral","highestDevelopmentStatusID":"1","companyTruncated":"SCF Pharma \/ Institut de recherche clinique du littoral"},{"orgOrder":0,"company":"VIST","sponsor":"Slovenian Research and Innovation Agency | Tosla d.o.o.","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Hydrolyzed Fish Collagen","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"VIST","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"VIST \/ Slovenian Research and Innovation Agency | Tosla d.o.o.","highestDevelopmentStatusID":"1","companyTruncated":"VIST \/ Slovenian Research and Innovation Agency | Tosla d.o.o."},{"orgOrder":0,"company":"Botanee Group","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Rosa Roxburghii","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Botanee Group","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Botanee Group \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Botanee Group \/ Inapplicable"},{"orgOrder":0,"company":"AMOREPACIFIC CORPORATION","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"SOUTH KOREA","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Apcp","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"AMOREPACIFIC CORPORATION","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"AMOREPACIFIC CORPORATION \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"AMOREPACIFIC CORPORATION \/ Inapplicable"},{"orgOrder":0,"company":"Ancient + Brave","sponsor":"Princeton Consumer Research","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Bovine Collagen","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Ancient + Brave","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ancient + Brave \/ Princeton Consumer Research","highestDevelopmentStatusID":"1","companyTruncated":"Ancient + Brave \/ Princeton Consumer Research"},{"orgOrder":0,"company":"VIST","sponsor":"Tosla d.o.o. | Slovenian Research and Innovation Agency","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Colagen","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"VIST","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"VIST \/ Tosla d.o.o. | Slovenian Research and Innovation Agency","highestDevelopmentStatusID":"1","companyTruncated":"VIST \/ Tosla d.o.o. | Slovenian Research and Innovation Agency"},{"orgOrder":0,"company":"Pierre Fabre","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"FRANCE","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"RV5026B","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Pierre Fabre","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pierre Fabre \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Pierre Fabre \/ Inapplicable"},{"orgOrder":0,"company":"Botanee Group","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"MLYAAT-1002","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Botanee Group","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Botanee Group \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Botanee Group \/ Inapplicable"},{"orgOrder":0,"company":"Ablon Skin Institute Research Center","sponsor":"U.S. Nutraceuticals, Inc. dba Valensa International","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Fatty Acid","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Ablon Skin Institute Research Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Gel","sponsorNew":"Ablon Skin Institute Research Center \/ U.S. Nutraceuticals, Inc. dba Valensa International","highestDevelopmentStatusID":"1","companyTruncated":"Ablon Skin Institute Research Center \/ U.S. Nutraceuticals, Inc. dba Valensa International"},{"orgOrder":0,"company":"Topix Skin Health","sponsor":"University of Minnesota","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Undisclosed","year":"2024","type":"Partnership","leadProduct":"ProteXidine","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Topix Skin Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Topix Skin Health \/ University of Minnesota","highestDevelopmentStatusID":"1","companyTruncated":"Topix Skin Health \/ University of Minnesota"},{"orgOrder":0,"company":"Clearstem Skincare","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2023","type":"Inapplicable","leadProduct":"Vitamin A","moa":"NR1B","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Clearstem Skincare","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Clearstem Skincare \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Clearstem Skincare \/ Citruslabs"},{"orgOrder":0,"company":"Scale Media Inc","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2024","type":"Inapplicable","leadProduct":"Vitamin","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Scale Media Inc","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Scale Media Inc \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Scale Media Inc \/ Citruslabs"},{"orgOrder":0,"company":"Standard Process Inc.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2025","type":"Inapplicable","leadProduct":"Vitamin C Supplement","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Standard Process Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Standard Process Inc. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Standard Process Inc. \/ Inapplicable"},{"orgOrder":0,"company":"Pressure BioSciences","sponsor":"QVC Skincare","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2022","type":"Partnership","leadProduct":"Vitamin A","moa":"NR1B","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Pressure BioSciences","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pressure BioSciences \/ QVC Skincare","highestDevelopmentStatusID":"1","companyTruncated":"Pressure BioSciences \/ QVC Skincare"},{"orgOrder":0,"company":"Zest Healthtech PLT","sponsor":"UCSI University","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"Melicope Ptelefolia Extract","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Zest Healthtech PLT","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Zest Healthtech PLT \/ UCSI University","highestDevelopmentStatusID":"1","companyTruncated":"Zest Healthtech PLT \/ UCSI University"},{"orgOrder":0,"company":"Olistic Research Labs S.L.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Olistic Research Labs S.L.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Olistic Research Labs S.L. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Olistic Research Labs S.L. \/ Undisclosed"},{"orgOrder":0,"company":"Olistic Research Labs S.L.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Olistic Research Labs S.L.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Olistic Research Labs S.L. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Olistic Research Labs S.L. \/ Undisclosed"},{"orgOrder":0,"company":"Center for Clinical and Cosmetic Research","sponsor":"Restore Biologics Holdings, LLC | Xtress\u00e9 (TM)","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Xtress\u00e9 Supplement","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Center for Clinical and Cosmetic Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Center for Clinical and Cosmetic Research \/ Restore Biologics Holdings, LLC | Xtress\u00e9 (TM)","highestDevelopmentStatusID":"1","companyTruncated":"Center for Clinical and Cosmetic Research \/ Restore Biologics Holdings, LLC | Xtress\u00e9 (TM)"},{"orgOrder":0,"company":"Two Lines LLC","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Two Lines LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Two Lines LLC \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Two Lines LLC \/ Citruslabs"},{"orgOrder":0,"company":"Contipro Pharma a.s","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"CZECH REPUBLIC","productType":"Other Small Molecule","year":"2025","type":"Inapplicable","leadProduct":"Hyaluronic Acid","moa":"Collagen synthesis","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Contipro Pharma a.s","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Gel","sponsorNew":"Contipro Pharma a.s \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Contipro Pharma a.s \/ Undisclosed"}]

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Bioiberica

                            Spain
                            Aquaexpo
                            Attending
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

                            Lead Product(s) : HA Matrix

                            Therapeutic Area : Dermatology

                            Study Phase : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Clinical Study to Evaluate the Anti-aging Efficacy of Dermial®

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            April 14, 2023

                            Lead Product(s) : HA Matrix

                            Therapeutic Area : Dermatology

                            Highest Development Status : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            Bioiberica Company Banner

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Two Lines LLC

                            Country arrow
                            ESCRS
                            Not Confirmed

                            Two Lines LLC

                            Country arrow
                            ESCRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Dermatology

                            Study Phase : Undisclosed

                            Sponsor : Citruslabs

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Hair Care Products on Grey Hair & Hair Health

                            Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Hair Aging.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            August 14, 2025

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Dermatology

                            Highest Development Status : Undisclosed

                            Sponsor : Citruslabs

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Olistic Research Labs S.L.

                            Country arrow
                            ESCRS
                            Not Confirmed

                            Olistic Research Labs S.L.

                            Country arrow
                            ESCRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Dermatology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluation of Olistic Women Nutraceutical on Hair Growth & Hair Loss in Volunteers

                            Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Alopecia.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            August 08, 2025

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Dermatology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Olistic Research Labs S.L.

                            Country arrow
                            ESCRS
                            Not Confirmed

                            Olistic Research Labs S.L.

                            Country arrow
                            ESCRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Dermatology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Clinical Study of Nutraceutical Supplement on Hair Growth, Hair Loss, & Skin Improvement

                            Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Alopecia.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            August 08, 2025

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Dermatology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Contipro Pharma a.s

                            Czech Republic arrow
                            ESCRS
                            Not Confirmed

                            Contipro Pharma a.s

                            Czech Republic arrow
                            ESCRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Hyaluronic Acid

                            Therapeutic Area : Dermatology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Effect of Peroral Sodium Hyaluronate on the Skin

                            Details : Hyaluronic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Skin Diseases.

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            July 15, 2025

                            Lead Product(s) : Hyaluronic Acid

                            Therapeutic Area : Dermatology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Zest Healthtech PLT

                            Country arrow
                            ESCRS
                            Not Confirmed

                            Zest Healthtech PLT

                            Country arrow
                            ESCRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Melicope Ptelefolia Extract

                            Therapeutic Area : Dermatology

                            Study Phase : Undisclosed

                            Sponsor : UCSI University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Eczeva Supplementation and Skin Health

                            Details : Eczefolia Extract (Melicope Ptelefolia Extract) is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Eczema.

                            Product Name : Eczefolia Extract

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            July 03, 2025

                            Lead Product(s) : Melicope Ptelefolia Extract

                            Therapeutic Area : Dermatology

                            Highest Development Status : Undisclosed

                            Sponsor : UCSI University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            Center for Clinical and Cosmetic Research

                            Country arrow
                            ESCRS
                            Not Confirmed

                            Center for Clinical and Cosmetic Research

                            Country arrow
                            ESCRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Xtressé Supplement

                            Therapeutic Area : Dermatology

                            Study Phase : Undisclosed

                            Sponsor : Restore Biologics Holdings, LLC | Xtressé (TM)

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study of Supplement & Serum on Hair Growth in Women with Thinning Hair

                            Details : Xtressé Supplement is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Alopecia.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            June 27, 2025

                            Lead Product(s) : Xtressé Supplement

                            Therapeutic Area : Dermatology

                            Highest Development Status : Undisclosed

                            Sponsor : Restore Biologics Holdings, LLC | Xtressé (TM)

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            Sirona Biochem Corp

                            Canada arrow
                            ESCRS
                            Not Confirmed

                            Sirona Biochem Corp

                            Canada arrow
                            ESCRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Difluorocyclohexyloxyphenol

                            Therapeutic Area : Dermatology

                            Study Phase : Undisclosed

                            Sponsor : Promura GmbH

                            Deal Size : $2.1 million

                            Deal Type : Private Placement

                            DEALS_DEV arrow-down

                            Sirona Inks Strategic Investment And JV Deal with Promura GmbH

                            Details : The proceeds will be used to advance the ongoing research and development of TFC-1067 for the treatment of dyschromia.

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Undisclosed

                            April 22, 2025

                            Lead Product(s) : Difluorocyclohexyloxyphenol

                            Therapeutic Area : Dermatology

                            Highest Development Status : Undisclosed

                            Sponsor : Promura GmbH

                            Deal Size : $2.1 million

                            Deal Type : Private Placement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            Ablon Skin Institute Research Center

                            Country arrow
                            ESCRS
                            Not Confirmed

                            Ablon Skin Institute Research Center

                            Country arrow
                            ESCRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Fatty Acid

                            Therapeutic Area : Dermatology

                            Study Phase : Undisclosed

                            Sponsor : U.S. Nutraceuticals, Inc. dba Valensa International

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DER...

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            April 10, 2025

                            Lead Product(s) : Fatty Acid

                            Therapeutic Area : Dermatology

                            Highest Development Status : Undisclosed

                            Sponsor : U.S. Nutraceuticals, Inc. dba Valensa International

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            10

                            Simply Plus Co., Ltd.

                            Country arrow
                            ESCRS
                            Not Confirmed

                            Simply Plus Co., Ltd.

                            Country arrow
                            ESCRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Collagen

                            Therapeutic Area : Dermatology

                            Study Phase : Undisclosed

                            Sponsor : Chia Nan University of Pharmacy and Science

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluation of the Skin-Beautifying Effects of Collagen Drinks

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            March 28, 2025

                            Lead Product(s) : Collagen

                            Therapeutic Area : Dermatology

                            Highest Development Status : Undisclosed

                            Sponsor : Chia Nan University of Pharmacy and Science

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth